Inventor
NIWA MINEO
JP17 patents
Patents
17 patentsUS5532137AJul 2, 1996
Anti-FR-900506 substance antibodies and highly-sensitive enzyme immunoassay method
FUJISAWA PHARMACEUTICAL CO38 citations91
US5028531AJul 2, 1991
IGF-I fusion proteins; protection of IGF-I from degradation by host cell; and processes for the production thereof
FUJISAWA PHARMACEUTICAL CO33 citations90
US5753481AMay 19, 1998
L-sorbose dehydrogenase and novel L-sorbosone dehydrogenase obtained from gluconobacter oxydans T-100
FUJISAWA PHARMACEUTICAL CO16 citations82
US5019500AMay 28, 1991
IGF-I fusion proteins; protection of IGF-I from degradation by host cell proteases; and processes for the production thereof
FUJISAWA PHARMACEUTICAL CO18 citations82
US4745179AMay 17, 1988
59 Valine insulin-like growth factor I and process for production thereof
FUJISAWA PHARMACEUTICAL CO21 citations82
US6197562B1Mar 6, 2001
L-sorbose dehydrogenase and novel L-sorbosone dehydrogenase obtained from gluconobacter oxydans T-100
FUJISAWA PHARMACEUTICAL CO7 citations74
US5888786AMar 30, 1999
Method for producing 2-keto-L-gulonic acid
FUJISAWA PHARMACEUTICAL CO8 citations74
US5861292AJan 19, 1999
L-sorbose dehydrogenase and novel L-sorbosone dehydrogenase obtained from Gluconobacter oxydans T-100
FUJISAWA PHARMACEUTICAL CO10 citations74
US5834263ANov 10, 1998
Method for producing 2-keto-L-gulonic acid
FUJISAWA PHARMACEUTICAL CO12 citations74
US5336613AAug 9, 1994
Cephalosporin C acylase
FUJISAWA PHARMACEUTICAL CO12 citations74
US5840533ANov 24, 1998
Tissue plasminogen activator
FUJISAWA PHARMACEUTICAL CO9 citations72
US5648250AJul 15, 1997
Tissue plasminogen activator
FUJISAWA PHARMACEUTICAL CO13 citations72
US5576183ANov 19, 1996
Monoclonal antibody recognizing FK506-binding protein, method for assaying FK506-binding protein level, and kit therefor
FUJISAWA PHARMACEUTICAL CO8 citations70
US5102985AApr 7, 1992
Process for the formation of intramolecular disulfide bridge in a polypeptide
FUJISAWA PHARMACEUTICAL CO4 citations63
US5340725AAug 23, 1994
Expression vector for insulin-like growth factor I and method of production
FUJISAWA PHARMACEUTICAL CO4 citations62
US5804429ASep 8, 1998
Cephalosporin C acylase
FUJISAWA PHARMACEUTICAL CO5 citations59
US6403336B1Jun 11, 2002
Process for the production of α-human atrial natriuretic polypeptide
FUJISAWA PHARMACEUTICAL CO1 citations52